In response to this request, Archie Kalokerinos, MD, and Ian Dettman, PhD, wish to offer information regarding the treatment of conditions arising from the following :
Vitamin C megadose therapy has been extensively documented to rapidly resolve a number of non-viral infectious diseases. These include:
So here we have a therapeutic (Vitamin C) that not only has the potential to kill the anthrax microbe, but should also neutralize the toxin. But, having said this, it is ABSOLUTELY ESSENTIAL to deliver sufficient Vitamin C to have the expected beneficial therapeutic effect.
Klenner (1971) would give an initial dose as high as 700mg of sodium ascorbate per kg of body weight, which could exceed 70 grams for a large man. He would repeat this high dose in a few hours if there was no drop in fever or a clear clinical improvement. In the absence of an MD to administer an intravenous injection, massive amounts may be taken orally as described by Cathcart (1981) - this may involve consuming up to several hundred grams of Vitamin C during a single day (sodium ascorbate, I.V. or orally, or, in those who can tolerate it, ascorbic acid, orally only).
Many studies on the role of megadose Vitamin C have been performed over the decades, but the doses have ALWAYS been too small. We highly recommend reading Klenner (1971) and Cathcart (1981) before taking a stand on the usefulness of MEGAdose Vitamin C therapy in treating a whole range of biological, chemical, and radiation induced diseases that threaten our modern civilization. The threat is now very real - and potential life-saving therapies can no longer be ignored merely for reasons of politics, profit, or tenure. Our country's very existence is at stake.
We should point out that the various terrorist organizations, even having nuclear or chemical weapons, only have the capability of killing several million people. On the other hand, a modest amount of a potent biological weapon can replicate and, in short order, spread worldwide, killing hundreds of millions, or even billions of people. At a price of less than ½ cent per gram of Vitamin C, the USA lacks only the knowledge and courage to protect its citizens using an "alternative" method that the AMA and the pharmaceutical companies will reject even in times of emergency and great national risk.
For further information please contact Archie Kalokerinos MD, or Ian Dettman, PhD, by emailing: email@example.com.
Brossier, F. and Mock M. (2001) " Toxins of Bacillus Anthracis" in Toxicon: Official Journal of the International Society on Toxicology 39(11): 1747-1755.
Cathcart, R. (1981) "Vitamin C, Titrating to Bowel Tolerance, Anascorbemia and Acute Induced Scurvy" in Medical Hypothesis 7(11): 1359-1376.
Dey, P. (1966) "Efficacy of Vitamin C in Counteracting Tetanus Toxicity" in Naturwissenschaften 53(12):310.
Hwi, K. et al, (1965) "A Study of Therapeutic Effect of Large Dosages of Injected Ascorbic Acid on the Depression of the Central Nervous System as in Acute Poisoning due to Barbiturates", Acta Pharmaceutica Sinica (Peking), vol 12:pp764-765.
Jungeblut, C. and Zwemer R. (1935) "Inactivation of Diphtheria Toxin in vivo and in vitro by Crystalline Vitamin C (Ascorbic Acid)" in Proceedings of the Society for Experimental Biology and Medicine 32: 1229-1234.
Klenner, F. (1949) "The Treatment of Poliomyelitis and other Virus Diseases with Vitamin C", Southern Medicine & Surgery, 111(7):209-214. www.nutri.com/49
Klenner, F. (1951) "Massive Doses of Vitamin C and the Virus Diseases", Southern Medicine & Surgery, 103(4):101-107.
Klenner, F. (1953) "The Use of Vitamin C as an Antibiotic", Journal of Applied Nutrition, 6:274-278.
Klenner, F. (1954) "Recent Discoveries in the Treatment of Lockjaw with Vitamin C and Tolserol", Tri-State Medical Journal, pp7-11.
Klenner, F. (1971) "Observations on the Dose and Administration of Ascorbic Acid when Employed Beyond the Range of a Vitamin in Human Pathology", Journal of Applied Nutrition, 23(3&4):61-88. http://www.nutri.com/wn/klenner.html
Klenner, F. (1974) "Significance of High Daily Intake of Ascorbic Acid in preventive medicine", Journal of the International Academy of Preventive Medicine, 1(1):45-69.
Lurie, J. (1965) "Benzene Intoxication and Vitamin C", Transactions of the Association of Industrial Medical Officers, vol 15:pp78-79.
Otani, T. (1936) "On the Vitamin C Therapy of Pertussis", Klinische Wochenschrift, 15(51):pp1884-1885.
Otani, T. (1939) "Influence of Vitamin C (L-ascorbic acid) upon the Whooping Cough Bacillus and its Toxin", Oriental Journal of Diseases of Infants, 25:1-4.
Ormerod, M., B. Unkauf, and F. White (1937), "A Further Report on the Ascorbic Acid Treatment of Whooping Cough", Canadian Medical Association Journal, 37(3):268-272.
Shapiro, B., et al, (1965) "Ascorbic Acid Protection against Inactivation of Lysozyme and Aldolase by Ionizing Radiation", US Airforce School of Aerospace Medicine, SAM-TR-65-71:pp1-3.
Shapiro, B. and Kollman G. (1967), "Protection by Ascorbic Acid against Radiation Damage in vitro", Journal of the Albert Einstein Medical Centre (Philadelphia), vol 15:pp63-70.
Ian Dettman, PhD (Biochemistry, Monash Univ., Melbourne) FRMIT (Microbiology and Biochemistry). Biological Therapies Factory 5, 20-30 Malcolm Rd Braeside Vic. Australia 3195 Ph. 011 61 395 87 3948 Fx: 011 61 395 87 1720 email: biol AT biol.com.au
Archie Kalokerinos, M.D. (Physician & Surgeon, London, Sydney) RMB 218ZA Bournes Lane Tamworth 2340 Australia Ph: 011 61 267 60 8166 Fx: 011 61 267 60 8344